CUMBERLAND PHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cumberland Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Cumberland Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$1.9M, a 69.8% increase year-over-year.
  • Cumberland Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$6.48M, a 3.19% decline year-over-year.
  • Cumberland Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$6.48M, a 3.19% decline from 2023.
  • Cumberland Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$6.28M, a 12.7% decline from 2022.
  • Cumberland Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$5.57M, a 58.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$6.48M -$200K -3.19% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 -$6.28M -$709K -12.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
2022 -$5.57M -$2.06M -58.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$3.51M -$168K -5.04% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-13
2020 -$3.34M +$198K +5.61% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 -$3.54M +$3.43M +49.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 -$6.96M +$1.02M +12.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 -$7.98M -$7.03M -745% Jan 1, 2017 Dec 31, 2017 8-K 2020-12-10
2016 -$945K -$1.68M -229% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $731K -$1.69M -69.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 $2.42M +$4.53M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-13
2013 -$2.1M -$7.95M -136% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $5.84M +$185K +3.26% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-09
2011 $5.66M +$3.2M +130% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-11
2010 $2.46M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.